Rangers “optimistic” about locking up Mike Napoli this winter

9 Comments

Rangers catcher Mike Napoli is currently scheduled to become a free agent at the conclusion of the 2012 season. But the Texas front office is hoping that he won’t even get a whiff of the open market.

According to FOX Sports’ Jon Paul Morosi, the Rangers are going to attempt to sign Napoli to a multi-year extension later this winter and are “optimistic” that something will get done.

Napoli posted a fantastic .320/.414/.631 slash line across 113 games this past year for the American League-champion Rangers. His value has never been higher and the Rangers will likely have to spend big in order to lock him up long-term, but the fact that they’re not in the running for any of the elite free agents on the market this winter (beyond perhaps C.J. Wilson) might serve as an indication that the club has cash at the ready for the 30-year-old slugger.

Napoli earned a $5.8 million salary in 2011 as a third-year arbitration-eligible player.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.